<?xml version="1.0"?><?xml-stylesheet type="text/xsl" href="../../web/xslt/drug-table.xslt"?><drug name = "fludarabine inj VIAL>
<dose><value>25</value>
</dose><route><value>IV</value>
</route><form><value>inj VIAL</value>
</form><drug><value>fludarabine inj VIAL</value>
</drug><strength><value>25 mg/mL</value>
</strength><frequency><value>DAILY</value>
<value>ONCE</value>
</frequency><instruction><value>for 5 days. Administer dose diluted in 50 mL 0.9% sodium chloride over 30 minutes.</value>
<value>for 3 days. Administer dose diluted in 100 mL 0.9% sodium chloride over 30 minutes.</value>
<value>Administer dose diluted in 100 mL 0.9% sodium chloride over 30 minutes.</value>
</instruction><volume><value>2 mL</value>
</volume><units><value>mg/m2/day</value>
</units><additionalnotes><value>Chronic Lymphocytic Leukemia, Waldenstrom&amp;apos;s Macroglobulinemia, Low Grade Lymphoma. In patients with CrCl from 30 to 70 mL/minute, decrease dose by 50%. Contraindicated in patients with CrCl less than 30 mL/minute.</value>
<value>Chronic Lymphocytic Leukemia</value>
</additionalnotes><population><value>ADULT</value>
</population><indicationprn><value></value>
</indicationprn><backgroundinformation><value>http://intraweb01.albertahealthservices.ca/Pharmacy/AHS_FORMULARY/search_details.aspx?id=3317</value>
</backgroundinformation><prninformation><value></value>
</prninformation><ahsformularystatus><value>Formulary.</value>
</ahsformularystatus><ahfsname><value>Antineoplastic Agents</value>
</ahfsname><highalert><value>YES</value>
</highalert><maximumprndose><value>YES</value>
</maximumprndose></drug>